Compliance with practice guidelines for node-negative breast cancer

Journal of Clinical Oncology

Volumn 15, Issue 1, 1997, Pages 216-222

  Olivotto, A ^a   Coldman, A J ^a   Hislop, T G ^a   Trevisan, C H ^a   Kula, J ^a   Goel, V ^a   Sawka, C ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031014006     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.1.216     Document Type: Article

References (25)

1. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 399:1-15, 71-85, 1992
2. Bonadonna G, Valagussa P, Moliterni A, et al: Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-positive breast cancer: The results of 20 years of follow-up. N Engl J Med 332:901-906, 1995
3. Olivotto IA, Bajdik C, Plenderleith IH, et al: Adjuvant systemic-therapy and survival from breast cancer. N Engl J Med 330:805-810, 1994
4. Field MJ, Lohr KN (eds): Guidelines for Clinical Practice. From Development to Use. Washington, DC, National Academy Press, 1992
5. Browman GR, Levine MN, Mohide A, et al: The practice guidelines development cycle: A conceptual tool for practice guidelines development and implementation. J Clin Oncol 13:502-512, 1995
6. Johnson TP, Ford L, Warnecke RB, et al: Effect of a National Cancer Institute clinical alert on breast cancer practice patterns. J Clin Oncol 12:1783-1788, 1994
7. Studnicki J, Schapira DV, Bradham DD, et al: Response to the National Cancer Institute clinical alert. The effect of practice guidelines on two hospitals in the same medical community. Cancer 72:2986-2992, 1993
8. Grimshaw J, Freemantle N, Wallace S, et al: Developing and implementing clinical practice guidelines. Qual Health Care 4:55-64, 1995
9. Lomas J: Words without action? The production, dissemination and impact of consensus recommendations. Ann Rev Publ Health 12:41-65, 1991
10. Greco PJ, Eisenberg JM: Changing physicians' practices. N Engl J Med 329:1271-1274, 1993
11. McCarthy M, Bore J: Treatment of breast cancer in two teaching hospitals: A comparison with consensus guidelines. Eur J Cancer 27:579-582,1991
12. McFall SL, Warnecke RB, Kaluzany AD, et al: Physician and practice characteristics associated with judgements about breast cancer treatment. Med Care 32:106-117, 1994
13. Goel V, Olivotto IA, Hislop TG, et al: Impact of provincial treatment guidelines on the locoregional management of node-negative breast cancer. Clin Invest Med 18:131, 1995 (suppl, abstr 844)
14. Sawka C, Olivotto IA, Coldman AJ, et al: The impact of provincial treatment guidelines on systemic adjuvant therapy for node-negative breast cancer. Clin Invest Med 18:89, 1995 (suppl, abstr 596)
15. McBride MI, Donaldson L: Ascertainment and data collection for a cancer registry. Br Columbia Med J 29:30-40, 1987
16. Breslow NE, Day NE: Statistical Methods in Cancer Research, Vol 1. The Analysis of Case-Control Studies. Lyon, France, IARC Scientific, no. 32, 1980
17. Fisher B, Redmond C, Dimitrov NV, et al: A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 320:473-478, 1989
18. Mansour EG, Gray R, Shatila AH, et al: Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer: An Intergroup study. N Engl J Med 320:485-490, 1989
19. McGuire WL: Adjuvant therapy of node-negative breast cancer. N Engl J Med 320:525-527, 1989 (editorial)
20. Devita VT Jr: Breast cancer therapy: Exercising all our options. N Engl J Med 320:527-529, 1989 (editorial)
21. Clark RM, McCulloch PB, Levine MN, et al: Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84:683-689, 1992
22. Veronesi U, Luini A, Del Vecchio M, et al: Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 328:1587-1591, 1993
23. National Cancer Institute: State-of-the-art statement for breast cancer, in Physician's Data Query. Bethesda, MD, National Cancer Institute, January 1991
24. Anonymous: Treatment of early-stage breast cancer. National Institute of Health Consensus Development Conference. JAMA 265:391-395, 1991 (abstr)
25. TNM Atlas (ed 3). New York, NY, Springer-Verlag, 1992